| ILP | inadequate luteal phase; insufficiency of luteal phase; interstitial laser photocoagulation; interst... |
|---|---|
| SPIA | solid-phase immunoabsorption; solid-phase immunoassay |
| CNV | choroidal neovascularization; contingent negative variation; cutaneous necrotizing vasculitis |
| CV | cardiac volume; cardiovascular; carotenoid vesicle; cell volume; central venous; cephalic vein; cere... |
| NV | nausea and vomiting; negative variation; neovascularization; next visit; nonveteran; normal value; n... |
| Phase I | phase |
|---|---|
| S phase | synthesis phase |
| CV | Coefficient of Variation |
| COV | Coefficient of variation |
| CV | coefficient variation |
| phase variation | <microbiology> Alteration in the expression of surface antigens by bacteria. For example: Salmonella can express either of two forms of flagellin, H1 and H2, that are coded by different genes. Control of which form is expressed is brought about by inversion of the promoter for the H2 gene, which if functional (noninverted) is associated with the expression of H2 and the production of a repressor of the H1 gene. Inversion occurs about every 1000 bacterial divisions and is under the control of another gene, hin, that is within the invertable sequence. (31 Dec 1997) |
|---|---|
| flagellar | Relating to a flagellum or to the extremity of a protozoan. (05 Mar 2000) |
| flagellar agglutinin | An agglutinin that is formed as the result of stimulation by, and which reacts with, the thermolabile antigen(s) in the flagella of motile strains of microorganisms. Synonym: flagellar agglutinin. See ABO blood group. (05 Mar 2000) |
| flagellar antigen | The heat-labile antigen's associated with bacterial flagella, in contrast to somatic antigen. See: H antigen. (05 Mar 2000) |
| antigenic variation | The phenomenon of changes in surface antigens in parasitic populations of Trypanosoma and Plasmodium (and some other parasitic protozoa) in order to escape immunological defense mechanisms. at least 100 different surface proteins have been found to appear and disappear during antigenic variation in a clone of trypanosomes. Each antigen is encoded in a separate gene. Antigenic variation is also known to occur in free living Protozoa and certain bacteria. (18 Nov 1997) |
| variation | In genetics, deviation in characters in an individual from those typical of the group to which it belongs, also, deviation in characters of the offspring from those of its parents. (18 Nov 1997) |
| variation (genetics) | The phenotypic differences among individuals in a population. (12 Dec 1998) |
| coefficient of variation | The ratio of the standard deviation to the mean. (05 Mar 2000) |
| contingent negative variation | An increasing negative shift of the cortical electrical potentials associated with an anticipated response to an expected stimulus. It is an electrical event indicative of a state of readiness or expectancy. (12 Dec 1998) |
| somaclonal variation | The variation between individuals in a clone, particularly in plant clones. While the objective is usually to grow clones without variation, somaclonal variation does provide the opportunity to generate new plant types that would be harder or impossible to generate by conventional plant breeding. (14 Nov 1997) |
| isotypic variation | <immunology> Variability of antigens common to all members of a species, for example the five classes of immunoglobulins found in humans. See: idiotype and allotype. (18 Nov 1997) |
| observer variation | The failure by the observer to measure or identify a phenomenon accurately, which results in an error. Sources for this may be due to the observer's missing an abnormality, or to faulty technique resulting in incorrect test measurement, or to misinterpretation of the data. Two varieties are inter-observer variation (the amount observers vary from one another when reporting on the same material) and intra-observer variation (the amount one observer varies between observations when reporting more than once on the same material). (12 Dec 1998) |
| accelerated phase of leukaemia | Refers to chronic myelogenous leukaemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase, but not as high as in the blast phase. (12 Dec 1998) |
| acceleration phase | <cell biology, cell culture> A period of increasing growth before the log phase in a culture of microbes. After the culture is started on a medium, at first there is no growth (the lag phase) and then the microbes start to gradually grow (acceleration phase) until they reach a constant maximum rate of growth (log phase). (15 Jan 1998) |
| acute-phase protein | <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor). Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold. Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability. These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers. See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity. (25 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|